How useful are B-type natriuretic peptide measurements for monitoring changes in patent ductus arteriosus shunt magnitude

Journal of Perinatology

Volumn 30, Issue 12, 2010, Pages 780-785

  Chen, S ^a   Tacy, T ^a   Clyman, R ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BNP; ductus ligation; indomethacin; patent ductus arteriosus

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CHILD HOSPITALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HUMAN; INFANT; MALE; PATENT DUCTUS ARTERIOSUS; PATIENT MONITORING; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

CARDIOVASCULAR AGENTS; DUCTUS ARTERIOSUS, PATENT; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMANS; INDOMETHACIN; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS;

EID: 78649646298     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2010.47     Document Type: Article

References (37)

1. Gerhardt T, Bancalari E. Lung compliance in newborns with patent ductus arteriosus before and after surgical ligation. Biol Neonate 1980; 38: 96-105.
2. Naulty CM, Horn S, Conry J, Avery GB. Improved lung compliance after ligation of patent ductus arteriosus in hyaline membrane disease. J Pediatr 1978; 93: 682-684.
3. Stefano JL, Abbasi S, Pearlman SA, Spear ML, Esterly KL, Bhutani VK. Closure of the ductus arteriosus with indomethacin in ventilated neonates with respiratory distress syndrome. Effects of pulmonary compliance and ventilation. Am Rev Respir Dis 1991; 143: 236-239.
4. Yeh TF, Thalji A, Luken L, Lilien L, Carr I, Pildes RS. Improved lung compliance following indomethacin therapy in premature infants with persistent ductus arteriosus. Chest 1981; 80: 698-700. (Pubitemid 12247517)
5. Szymankiewicz M, Hodgman JE, Siassi B, Gadzinowski J. Mechanics of breathing after surgical ligation of patent ductus arteriosus in newborns with respiratory distress syndrome. Biol Neonate 2004; 85: 32-36.
6. Cotton RB, Stahlman MT, Berder HW, Graham TP, Catterton WZ, Kover I. Randomized trial of early closure of symptomatic patent ductus arteriosus in small preterm infants. J Pediatr 1978; 93: 647-651.
7. Al Faleh K, Smyth J, Roberts R, Solimano A, Asztalos E, Schmidt B. Prevention and 18-month outcome of serious pulmonary hemorrhage in extremely low birth weight infants: Results from the triall of indomethacin prophylaxis in preterms. Pediatrics 2008; 121: e233-e238.
8. Domanico RS, Waldman JD, Lester LA, McPhillips HA, Catrambone JE, Covert RF. Prophylactic indomethacin reduces the incidence of pulmonary hemorrhage and patent ductus arteriosus in surfactant treated infants <1250 grams. Pediatr Res 1994; 35: 331.
9. Clyman RI, Chorne N. Patent ductus arteriosus: Evidence for and against treatment. J Pediatr 2007; 150: 216-219.
10. Clyman RI, Chorne N. Pda treatment: Effects on pulmonary hemorrhage and pulmonary morbidity. J Pediatr 2008; 152: 447-448.
11. El-Khuffash A, Molloy EJ. Are b-type natriuretic peptide (bnp) and n-terminal-pro-bnp useful in neonates? Arch Dis Child Fetal Neonatal Ed 2007; 92: F320-F324.
12. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321-328.
13. Wieczorek SJ, Wu AH, Christenson R, Krishnaswamy P, Gottlieb S, Rosano T et al. A rapid b-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: A multicenter evaluation. Am Heart J 2002; 144: 834-839.
14. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A. Utility of a rapid b-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002; 39: 202-209.
15. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P et al. Rapid measurement of b-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002; 347: 161-167.
16. Flynn PA, da Graca RL, Auld PA, Nesin M, Kleinman CS. The use of a bedside assay for plasma b-type natriuretic peptide as a biomarker in the management of patent ductus arteriosus in premature neonates. J Pediatr 2005; 147: 38-42.
17. Da Graca RL, Hassinger DC, Flynn PA, Sison CP, Nesin M, Auld PA. Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics 2006; 117: 2183-2189.
18. Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S et al. Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: Marked and rapid increase after birth. Eur J Endocrinol 1995; 133: 207-209.
19. Holmstrom H, Hall C, Thaulow E. Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 2001; 90: 184-191.
20. Czernik C, Lemmer J, Metze B, Koehne PS, Mueller C, Obladen M. B-type natriuretic peptide to predict ductus intervention in infants <28 weeks. Pediatr Res 2008; 64: 286-290
21. Sanjeev S, Pettersen M, Lua J, Thomas R, Shankaran S, L'Ecuyer T. Role of plasma b-type natriuretic peptide in screening for hemodynamically significant patent ductus arteriosus in preterm neonates. J Perinatol 2005; 25: 709-713.
22. Puddy VF, Amirmansour C, Williams AF, Singer DR. Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond) 2002; 103: 75-77.
23. Choi BM, Lee KH, Eun BL, Yoo KH, Hong YS, Son CS et al. Utility of rapid b-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005; 115: e255-e261.
24. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M et al. Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003; 57: 191-197.
25. Nagaya N, Nishikimi T, Okano Y, Uematsu M, Satoh T, Kyotani S et al. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension. J Am Coll Cardiol 1998; 31: 202-208. (Pubitemid 28064743)
26. Takami Y, Horio T, Iwashima Y, Takiuchi S, Kamide K, Yoshihara F et al. Diagnostic and prognostic value of plasma brain natriuretic peptide in non-dialysis-dependent crf. Am J Kidney Dis 2004; 44: 420-428.
27. Koch A, Zink S, Singer H. B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006; 27: 861-866.
28. Farombi-Oghuvbu I, Matthews T, Mayne PD, Guerin H, Corcoran JD. N-terminal pro-b-type natriuretic peptide: A measure of significant patent ductus arteriosus. Arch Dis Child Fetal Neonatal Ed 2008; 93: F257-F260.
29. Ikemoto Y, Nogi S, Teraguchi M, Kojima T, Hirata Y, Kobayashi Y. Early changes in plasma brain and atrial natriuretic peptides in premature infants: Correlation with pulmonary arterial pressure. Early Hum Dev 1996; 46: 55-62.
30. Tanaka T, Kanda T, Takahashi T, Saegusa S, Moriya J, Kurabayashi M. Interleukin-6-induced reciprocal expression of serca and natriuretic peptides mrna in cultured rat ventricular myocytes. J Int Med Res 2004; 32: 57-61.
31. Koch A, Singer H. Normal values of b type natriuretic peptide in infants, children, and adolescents. Heart 2003; 89: 875-878.
32. Keller RL, Tacy TA, Fields S, Ofenstein JP, Aranda JV, Clyman RI. Combined treatment with a non-selective nitric oxide synthase inhibitor (l-nmma) and indomethacin increases ductus constriction in extremely premature newborns. Pediatric Research 2005; 58: 1216-1221.
33. Suzumura H, Nitta A, Tanaka G, Arisaka O. Diastolic flow velocity of the left pulmonary artery of patent ductus arteriosus in preterm infants. Pediatr Int 2001; 43: 146-151.
34. El Hajjar M, Vaksmann G, Rakza T, Kongolo G, Storme L. Severity of the ductal shunt: A comparison of different markers. Arch Dis Child Fetal Neonatal Ed 2005; 90: F419-F422.
35. Evans N, Iyer P. Assessment of ductus arteriosus shunt in preterm infants supported by mechanical ventilation: Effect of interatrial shunting. J Pediatr 1994; 125: 778-785.
36. Ruskoaho H. Cardiac hormones as diagnostic tools in heart failure. Endocr Rev 2003; 24: 341-356.
37. Holmstrom H, Omland T. Natriuretic peptides as markers of patent ductus arteriosus in preterm infants. Clin Sci (Lond) 2002; 103: 79-80.